Clinical trials: Microwave
Dysfunctional Uterine Bleeding
Endometrial Ablation With Non-hysteroscopic Methods
Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach.
- Trial name
- NCT01173965
- Testing
- MEA, Novasure
- Where
- 2 sites in Greece
- Volunteers
- 66 people
- Sponsor
- Aristotle University Of Thessaloniki
Hepatocellular Carcinoma, Obesity
Central Obesity and Hepatocellular Carcinoma
Recurrence and metastases after microwave ablation(MWA) of hepatocellular carcinoma(HCC) are the major factors that influence the survival.
- Conditions
- Hepatocellular Carcinoma, Obesity, Microwave Ablation
- Trial name
- NCT03082378
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Chinese PLA General Hospital
Liver Neoplasms
Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
Microwave ablation (MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate the variability and reproducibility of single-probe MWA versus radiofrequency ablation (RFA)…
- Trial name
- LiverMWA1 (NCT00922181)
- Testing
- Microwave ablation, Radiofrequency ablation
- Where
- Belgium
- Volunteers
- 19 people
- Sponsor
- University Hospital, Gasthuisberg
Breast Tumor, Microwave Ablation
Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor
The investigators will perform this study to prospectively compare the clinical outcome after percutaneous microwave ablation(MWA) and breast conserving surgery of benign and malignant breast lesion under ultrasound (US) guidance.
- Conditions
- Breast Tumor, Microwave Ablation, Breast Conserving Surgery
- Trial name
- NCT04626986
- Testing
- microwave ablation, breast conserving surgery
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Chinese PLA General Hospital
Breast Cancer
Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer
Ablative therapy, as a local treatment modality for tumors, has an immune activating effect. To explore the synergistic effect of microwave ablation combined with PD-1 inhibitors, this prospective, open-label, multi-cohort…
- Trial name
- NCT04805736
- Testing
- Microwave Ablation, Camrelizumab, Breast Surgery
- Where
- China
- Volunteers
- 60 people
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
Liver Cancer, Surgery
Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo Trial
In primary and secondary liver tumors microwave ablation could be an alternative to surgical resection.It could be performed laparoscopically.
- Conditions
- Liver Cancer, Surgery, Navigation, Spatial
- Trial name
- NCT04106453
- Testing
- navigated microwave ablation, ultrasound guided navigation
- Where
- Germany
- Volunteers
- 4 people
- Sponsor
- Universitätsklinikum Köln
Lung Cancer
Transbronchial Ablation for Peripheral Lung Tumor
The objective of the study was to evaluate the efficacy and safety of navigation bronchoscopy guided transbronchial ablation for the treatment of inoperable peripheral lung tumor.
- Trial name
- NCT02972177
- Testing
- Radiofrequency ablation, Microwave ablation
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Shanghai Chest Hospital
Liver Cancer, Liver Metastasis Colon Cancer
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies.
- Conditions
- Liver Cancer, Liver Metastasis Colon Cancer, Kidney Cancer, Renal Cell Carcinoma
- Trial name
- NCT03981497
- Testing
- Microwave ablation (MWA)
- Where
- Italy
- Volunteers
- 500 people
- Sponsor
- Francesco De Cobelli
Overall Survival, Progression-free Survival
Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma
As the most common subtype of liver cancer (85% ~ 90%), HCC is highly malignant; thus, one of the crucial issues in HCC management is an effective therapy for tumors at an early stage, which is vital for improving the prognosis…
- Conditions
- Overall Survival, Progression-free Survival, Cost
- Trial name
- NCT05796700
- Testing
- Microwave Ablation
- Volunteers
- 1,585 people
- Sponsor
- Chinese PLA General Hospital
Recurrent Hepatocellular Carcinoma, Lenvatinib
The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
Studies have shown that combination therapy of TACE with Lenvatinib could achieve better survival outcomes than TACE alone for hepatocellular carcinoma (HCC) at BCLC B stage.
- Conditions
- Recurrent Hepatocellular Carcinoma, Lenvatinib, Local Therapy, Ablation
- Trial name
- NCT06609850
- Testing
- TACE, Ablation, Lenvatinb
- Where
- China
- Volunteers
- 116 people
- Sponsor
- Sun Yat-sen University
Sarcoma
BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]
Patients with sarcoma and lung metastases have few therapeutic options, with poor response to systemic treatment. Many of them are not eligible to surgical treatments due to the high number and distribution of pulmonary lesions…
- Trial name
- BORIS (NCT04510714)
- Testing
- Image guided percutaneous microwave ablation
- Where
- Brazil
- Volunteers
- 60 people
- Sponsor
- Instituto do Cancer do Estado de São Paulo
Colorectal Cancer Metastatic, Liver Metastases
A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis
Currently, comprehensive treatments for liver metastasis/pulmonary metastasis that cannot reach NED include systemic chemotherapy, interventional chemotherapy, molecular targeted therapy, immunotherapy, and local treatments…
- Conditions
- Colorectal Cancer Metastatic, Liver Metastases, Lung Metastases
- Trial name
- NCT04888806
- Testing
- Camrelizumab, ablation, chemotherapy
- Volunteers
- 37 people
- Sponsor
- Harbin Medical University
Hepatocellular Carcinoma, Liver Cancer
Microwave Ablation of Resectable Liver Tumors
The purpose of this protocol is to pathologically evaluate the destruction by microwave ablation of primary and metastatic liver tumors.
- Trial name
- NCT00892255
- Testing
- Microwave Ablation
- Where
- United States
- Sponsor
- St. Joseph Hospital of Orange
Lung Cancer
Transbronchial MWA for Pulmonary Tumors
The purpose of the study is to evaluate the efficacy and safety of transbronchial microwave ablation for lung cancer.
- Trial name
- NCT06969014
- Testing
- Microwave ablation
- Where
- China
- Volunteers
- 15 people
- Sponsor
- Shanghai Chest Hospital
Liver Cancer
Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels
Liver cancer including primary hepatocellular carcinoma (HCC) and metastatic liver cancers is one the most common malignancies in the world. Over 10000 new cases per year are diagnosed in Taiwan.
- Trial name
- NCT03063840
- Testing
- Microwave ablation
- Sponsor
- National Taiwan University Hospital
Stroke
Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase
This is a prospective, open, multicentre trial that will enrol patients with clinical signs of stroke in the acute phase admitted for CT scan. Follow-up microwave measurements will be performed after the acute phase.
- Trial name
- NCT02490306
- Testing
- Strokefinder MD100 measurement
- Where
- Sweden
- Volunteers
- 500 people
- Sponsor
- Mikael Elam
Liver Malignant Tumors
Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies
The purpose of this study is to determine the technical success rate of creating a safety margin of 5 mm or more including the tumor by performing image-guided percutaneous microwave thermal therapy using a microwave generator…
- Trial name
- NCT06426992
- Testing
- Starwave Microwave Ablation System, Microwave Ablation, Ultrasound-CT fusion guidance system
- Where
- South Korea
- Volunteers
- 128 people
- Sponsor
- Seoul National University Hospital
Prostate Cancer
Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer
Conventional treatment options for localized prostate cancer include prostatectomy, radiotherapy and active surveillance. However, prostatectomy and radiotherapy carry certain degree of morbidity, including the risks of urinary…
- Trial name
- NCT04113811
- Testing
- Biomedical TATO3® Microwave needle thermoablation device (Koelis, Grenoble, France)
- Where
- Hong Kong
- Volunteers
- 30 people
- Sponsor
- Chinese University of Hong Kong
Liver Tumor, Hepatocellular Carcinoma
NeuWave Microwave Ablation HCC China Study
This is a single-arm, prospective, multicenter, study. Individuals who are assessed for microwave (MW) ablation of HCC in accordance with their institution's standard of care (SOC), who meet study entry criteria and sign the…
- Trial name
- NW (NCT03783871)
- Testing
- Microwave ablation
- Where
- 4 sites in China
- Volunteers
- 135 people
- Sponsor
- Ethicon, Inc.
Hyperlactatemia
Pilot Testing a Novel Non-invasive Lactate Sensor
To test the efficacy and accuracy of a novel non-invasive lactate sensor in humans undergoing strenuous leg exercise.
- Trial name
- NCT05649358
- Testing
- Lactate sensor (Lactisense)
- Where
- Canada
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- University of Alberta